Respiratory Tract

  • 3E0F Respiratory Tract
    • 3E0F3 Percutaneous
      • 3E0F30 Antineoplastic
        • 3E0F304 Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach
        • 3E0F305 Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach
        • 3E0F30M Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach
      • 3E0F32 Anti-infective
        • 3E0F328 Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach
        • 3E0F329 Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach
      • 3E0F33 Anti-inflammatory
        • 3E0F33Z Introduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach
      • 3E0F36 Nutritional Substance
        • 3E0F36Z Introduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach
      • 3E0F37 Electrolytic and Water Balance Substance
        • 3E0F37Z Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach
      • 3E0F3B Anesthetic Agent
        • 3E0F3BZ Introduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach
      • 3E0F3G Other Therapeutic Substance
        • 3E0F3GC Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach
      • 3E0F3H Radioactive Substance
        • 3E0F3HZ Introduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach
      • 3E0F3K Other Diagnostic Substance
        • 3E0F3KZ Introduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach
      • 3E0F3N Analgesics, Hypnotics, Sedatives
        • 3E0F3NZ Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach
      • 3E0F3S Gas
        • 3E0F3SD Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach
        • 3E0F3SF Introduction of Other Gas into Respiratory Tract, Percutaneous Approach
      • 3E0F3T Destructive Agent
        • 3E0F3TZ Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach
    • 3E0F4 Percutaneous Endoscopic
      • 3E0F4G Other Therapeutic Substance
        • 3E0F4GC Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Endoscopic Approach
    • 3E0F7 Via Natural or Artificial Opening
      • 3E0F70 Antineoplastic
        • 3E0F704 Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening
        • 3E0F705 Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening
        • 3E0F70M Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F72 Anti-infective
        • 3E0F728 Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening
        • 3E0F729 Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F73 Anti-inflammatory
        • 3E0F73Z Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F76 Nutritional Substance
        • 3E0F76Z Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F77 Electrolytic and Water Balance Substance
        • 3E0F77Z Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7B Anesthetic Agent
        • 3E0F7BZ Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7G Other Therapeutic Substance
        • 3E0F7GC Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7H Radioactive Substance
        • 3E0F7HZ Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7K Other Diagnostic Substance
        • 3E0F7KZ Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7N Analgesics, Hypnotics, Sedatives
        • 3E0F7NZ Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7S Gas
        • 3E0F7SD Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening
        • 3E0F7SF Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening
      • 3E0F7T Destructive Agent
        • 3E0F7TZ Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening
    • 3E0F8 Via Natural or Artificial Opening Endoscopic
      • 3E0F80 Antineoplastic
        • 3E0F804 Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0F805 Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0F80M Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F82 Anti-infective
        • 3E0F828 Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0F829 Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F83 Anti-inflammatory
        • 3E0F83Z Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F86 Nutritional Substance
        • 3E0F86Z Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F87 Electrolytic and Water Balance Substance
        • 3E0F87Z Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8B Anesthetic Agent
        • 3E0F8BZ Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8G Other Therapeutic Substance
        • 3E0F8GC Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8H Radioactive Substance
        • 3E0F8HZ Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8K Other Diagnostic Substance
        • 3E0F8KZ Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8N Analgesics, Hypnotics, Sedatives
        • 3E0F8NZ Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8S Gas
        • 3E0F8SD Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
        • 3E0F8SF Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
      • 3E0F8T Destructive Agent
        • 3E0F8TZ Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic